Company Filing History:
Years Active: 2016-2022
Title: Innovations by Wayne Szeto: Pioneering Methods for Genomic Integration
Introduction
Wayne Szeto, an innovative inventor based in Emeryville, California, has made significant contributions to the field of genomic integration. With a total of four patents under his name, Szeto's work focuses on advancing the methods of integrating exogenous nucleic acids into host cell genomes, presenting promising applications in biotechnology and genetic engineering.
Latest Patents
One of his latest patents entails innovative methods for genomic integration. This patent outlines techniques for introducing one or more exogenous nucleic acids into selected target sites within a host cell's genome. Specifically, Szeto's methods involve the use of integration polynucleotides that include a nuclease capable of creating a break at the genomic target site, alongside linear nucleic acids that facilitate homologous recombination. This revolutionary approach enables the formation of circular extrachromosomal nucleic acids, including sequences for selectable markers, which are crucial for identifying successfully modified cells. Furthermore, his methods encompass selecting host cells that exhibit the desired selectable marker, enhancing the efficiency of the integration process.
Career Highlights
Wayne Szeto is currently employed at Amyris, Inc., a prominent biotechnology company specializing in the development of sustainable products. His role at Amyris allows him to leverage his immense expertise in the field while contributing to groundbreaking projects. His four patents reflect his commitment to enhancing genetic methodologies and addressing challenges in molecular biology.
Collaborations
Working alongside talented colleagues like Andrew Horwitz and Kristy Michelle Hawkins, Szeto has fostered a collaborative environment that cultivates innovation. Together, they contribute to groundbreaking research and advancements in the science of genomic integration.
Conclusion
Wayne Szeto stands out as a key figure in the biotech landscape, pushing the boundaries of what is possible with genomic integration methods. His four patents not only exemplify his ingenuity but also hold the potential to impact various scientific fields significantly. As he continues his work at Amyris, Inc., Szeto is poised to leave a lasting mark on the realm of biotechnology and genetic research.